|
MY200356A
(en)
|
|
Kras g12c inhibitors
|
|
PH12018501065A1
(en)
|
|
Compounds and compositions useful for treating disorders related to ntrk
|
|
MX380901B
(es)
|
|
Compuestos inhibidores de parg.
|
|
MX382339B
(es)
|
|
Inhibidores g12c de kras.
|
|
EP4116293A3
(en)
|
|
Rho kinase inhibitors
|
|
MX2018007421A
(es)
|
|
Compuestos inhibidores de quinasa de union a tank.
|
|
HK1210775A1
(en)
|
|
Imidazotriazinecarbonitriles useful as kinase inhibitors
|
|
MX370021B
(es)
|
|
Formulaciones eutécticas de clorhidrato de ciclobenzaprina y de clorhidrato de amitriptilina.
|
|
WO2015001504A3
(en)
|
|
Antibody formulations and methods
|
|
MX2019003618A
(es)
|
|
Inhibidores de pirimidinil tirosina cinasa.
|
|
PH12014501273A1
(en)
|
|
Intranasal dexmedetomidine compositions and methods of use thereof
|
|
WO2013185082A3
(en)
|
|
Inhibitors of bruton's tyrosine kinase
|
|
SG10201902203VA
(en)
|
|
Eutectic formulations of cyclobenzaprine hydrochloride
|
|
WO2011113060A3
(en)
|
|
Antiviral compounds and methods of use thereof
|
|
MX2018006700A
(es)
|
|
Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
|
|
MX2018016037A
(es)
|
|
Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa.
|
|
MX383812B
(es)
|
|
Compuesto novedoso de tiofeno 2,3,5-sustituido como inhibidor de la proteina cinasa.
|
|
WO2017147130A3
(en)
|
|
Direct fed microbial for prevention of shrimp disease
|
|
EP2575452A4
(en)
|
|
ANTIMICROBIAL COMPOSITIONS
|
|
WO2014160775A8
(en)
|
|
Compositions and methods for the treatment of malaria
|
|
WO2013185048A3
(en)
|
|
Heterocyclic guanidine f1f0-atpase inhibitors
|
|
WO2013019093A3
(en)
|
|
Novel aniline derivatives and use thereof
|
|
MX395385B
(es)
|
|
Composiciones antimicrobianas sólidas con solubilidad mejorada.
|
|
PH12017501692A1
(en)
|
|
Solid forms of menaquinols
|
|
MX383940B
(es)
|
|
Formulación farmacéutica que contiene tocol fosfato.
|